Development of new tools for de novo polyketide synthase design
Lead Participant:
ISOMERASE THERAPEUTICS LIMITED
Abstract
Development of new tools for rational biological synthesis of novel natural products with potential use in design of improved anti-infectives, anticancer agents, agrochemicals and immune modulating agents.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
ISOMERASE THERAPEUTICS LIMITED | £165,715 | £ 124,286 |
  | ||
Participant |
||
UNIVERSITY OF CAMBRIDGE | ||
INNOVATE UK | ||
UNIVERSITY OF CAMBRIDGE |
People |
ORCID iD |
Lesley Sheehan (Project Manager) |